NCT05993104Visszavonva
Shape vs Substrate in AF
Investigating the Interplay of Left Atrial Geometry With Abnormal Propagation Patterns in Atrial Fibrillation
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2024. febr. 21.
Megadott ok: Funder no longer operating so the study team is unable to deliver the study.
Rövid összefoglaló (regiszter, angolul)
Atrial fibrillation (AF) is an abnormal heart rhythm which originates from the top two chambers (atria) of the heart. It can cause significant symptoms and have severe consequences such as stroke. Catheter ablation is a treatment for AF. It is minimally invasive, involving thin tubes known as catheters, being inserted through a blood vessel in the groin and passed to the heart under X-ray guidance. Once in the heart, regions of tissue believed responsible for the abnormal heart rhythm can be identified, and hot or cold energy used to create scar at these areas, preventing the abnormal rhythm. Identifying these regions is a key challenge in making the treatment as effective as possible. The investigators believe that there may be a change in the shape of a participant's atria in these regions and as such identifying and treating areas of abnormal shape may be beneficial. To investigate this, the study team propose three phases. The first, uses previously collected data to make a model of what is average atrial geometry in AF. Investigators will then compare individual participants' atrial geometries to this average shape to identify areas of geometric abnormality and see how these correspond to areas of abnormal electrical activity. In the second phase, investigators will collect new data on how much atrial geometry changes during catheter ablation procedures. Finally, in the third phase, investigators will investigate whether including geometric assessment in the catheter ablation procedure is feasible from a work flow perspective.
- Állapot (regiszter)
- Visszavonva
- Vizsgálattípus
- Megfigyeléses
- Résztvevők száma
- 0 (tényleges)
- Első benyújtás
- 2023. júl. 5.
- Kezdés
- 2024. jan.
- Elsődleges befejezés
- 2026. szept.
- Fő szponzor
- Oxford University Hospitals NHS Trust
- Betegségek
- Pitvarfibrilláció
- NCT-szám
- NCT05993104
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Congenital cardiac abnormality.
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
Kiket keres a vizsgálat
- Retrospective component:
- Participant gave consent for anonymised data being utilised for clinical research at time of procedure.
- Male or Female, aged 18 years or above.
- Previous AcQMap guided ablation for paroxysmal or persistent atrial fibrillation.
- Prospective component:
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Diagnosed with paroxysmal or persistent atrial fibrillation and planned for an AcQMap guided catheter ablation procedure.
Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| John Radcliffe Hospital | Oxford | Egyesült Királyság | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.